APO Research
Talk to an analyst

APO RESEARCH · REPORT

Adjuvants

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Adjuvants Market Outlook and Growth Opportunities 2026

26 December 2025191 pages

Choose your research edition.

Industry ResearchAdjuvants Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Adjuvants Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Adjuvants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Adjuvants Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Adjuvants Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Adjuvants market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Adjuvants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Adjuvants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Adjuvants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Adjuvants market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Adjuvants market include GSK, Croda, CSL Limited, Phibro Animal Health, SDA BIO, SEPPIC, SPI Pharma, Vertellus and Huanuotai Biological, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Adjuvants market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Adjuvants and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Adjuvants sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Adjuvants market size, projected growth trends, production technologies, key applications, and end-use industries.

Adjuvants Segment by Company

GSK

Croda

CSL Limited

Phibro Animal Health

SDA BIO

SEPPIC

SPI Pharma

Vertellus

Huanuotai Biological

Rico Bio

Sanofi

Escon

Zhifei Biological

Adjuvants Segment by Type

Emulsion Adjuvants

Mineral Adjuvants

Others

Adjuvants Segment by Application

Human Vaccine

Veterinary Vaccine

Adjuvants Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Adjuvants status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Adjuvants market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Adjuvants significant trends, drivers, influence factors in global and regions.

6. To analyze Adjuvants competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adjuvants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Adjuvants market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Adjuvants industry.

Chapter 3: Detailed analysis of Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Adjuvants in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Adjuvants Industry Trends Table 2. Adjuvants Industry Drivers Table 3. Adjuvants Industry Opportunities and Challenges Table 4. Adjuvants Industry Restraints Table 5. Global Adjuvants Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Adjuvants Revenue Share by Company (2021-2026) Table 7. Global Adjuvants Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Adjuvants Sales Volume Share by Company (2021-2026) Table 9. Global Adjuvants Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Adjuvants Company Ranking, (2024-2026) & (USD Million) Table 11. Global Adjuvants Key Company Manufacturing Base & Headquarters Table 12. Global Adjuvants Company, Product Type & Application Table 13. Global Adjuvants Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Emulsion Adjuvants Table 18. Significant Companies of Mineral Adjuvants Table 19. Significant Companies of Others Table 20. Global Adjuvants Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Adjuvants Sales Volume by Type (2021-2026) & (Tons) Table 22. Global Adjuvants Sales Volume by Type (2027-2032) & (Tons) Table 23. Global Adjuvants Sales Volume Share by Type (2021-2026) Table 24. Global Adjuvants Sales Volume Share by Type (2027-2032) Table 25. Global Adjuvants Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Adjuvants Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Adjuvants Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Adjuvants Sales Value Share by Type (2021-2026) Table 29. Global Adjuvants Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Human Vaccine Table 31. Significant Companies of Veterinary Vaccine Table 32. Global Adjuvants Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global Adjuvants Sales Volume by Application (2021-2026) & (Tons) Table 34. Global Adjuvants Sales Volume by Application (2027-2032) & (Tons) Table 35. Global Adjuvants Sales Volume Share by Application (2021-2026) Table 36. Global Adjuvants Sales Volume Share by Application (2027-2032) Table 37. Global Adjuvants Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Adjuvants Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Adjuvants Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Adjuvants Sales Value Share by Application (2021-2026) Table 41. Global Adjuvants Sales Value Share by Application (2027-2032) Table 42. Global Adjuvants Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 43. Global Adjuvants Sales by Region (2021-2026) & (Tons) Table 44. Global Adjuvants Sales Market Share by Region (2021-2026) Table 45. Global Adjuvants Sales by Region (2027-2032) & (Tons) Table 46. Global Adjuvants Sales Market Share by Region (2027-2032) Table 47. Global Adjuvants Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Adjuvants Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Adjuvants Sales Value Share by Region (2021-2026) Table 50. Global Adjuvants Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Adjuvants Sales Value Share by Region (2027-2032) Table 52. Global Adjuvants Market Average Price (US$/Kg) by Region (2021-2026) Table 53. Global Adjuvants Market Average Price (US$/Kg) by Region (2027-2032) Table 54. Global Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. Global Adjuvants Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Adjuvants Sales by Country (2021-2026) & (Tons) Table 57. Global Adjuvants Sales Market Share by Country (2021-2026) Table 58. Global Adjuvants Sales by Country (2027-2032) & (Tons) Table 59. Global Adjuvants Sales Market Share by Country (2027-2032) Table 60. Global Adjuvants Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Adjuvants Sales Value Market Share by Country (2021-2026) Table 62. Global Adjuvants Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Adjuvants Sales Value Market Share by Country (2027-2032) Table 64. GSK Company Information Table 65. GSK Business Overview Table 66. GSK Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 67. GSK Adjuvants Product Portfolio Table 68. GSK Recent Development Table 69. Croda Company Information Table 70. Croda Business Overview Table 71. Croda Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 72. Croda Adjuvants Product Portfolio Table 73. Croda Recent Development Table 74. CSL Limited Company Information Table 75. CSL Limited Business Overview Table 76. CSL Limited Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 77. CSL Limited Adjuvants Product Portfolio Table 78. CSL Limited Recent Development Table 79. Phibro Animal Health Company Information Table 80. Phibro Animal Health Business Overview Table 81. Phibro Animal Health Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 82. Phibro Animal Health Adjuvants Product Portfolio Table 83. Phibro Animal Health Recent Development Table 84. SDA BIO Company Information Table 85. SDA BIO Business Overview Table 86. SDA BIO Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 87. SDA BIO Adjuvants Product Portfolio Table 88. SDA BIO Recent Development Table 89. SEPPIC Company Information Table 90. SEPPIC Business Overview Table 91. SEPPIC Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 92. SEPPIC Adjuvants Product Portfolio Table 93. SEPPIC Recent Development Table 94. SPI Pharma Company Information Table 95. SPI Pharma Business Overview Table 96. SPI Pharma Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 97. SPI Pharma Adjuvants Product Portfolio Table 98. SPI Pharma Recent Development Table 99. Vertellus Company Information Table 100. Vertellus Business Overview Table 101. Vertellus Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 102. Vertellus Adjuvants Product Portfolio Table 103. Vertellus Recent Development Table 104. Huanuotai Biological Company Information Table 105. Huanuotai Biological Business Overview Table 106. Huanuotai Biological Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 107. Huanuotai Biological Adjuvants Product Portfolio Table 108. Huanuotai Biological Recent Development Table 109. Rico Bio Company Information Table 110. Rico Bio Business Overview Table 111. Rico Bio Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 112. Rico Bio Adjuvants Product Portfolio Table 113. Rico Bio Recent Development Table 114. Sanofi Company Information Table 115. Sanofi Business Overview Table 116. Sanofi Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 117. Sanofi Adjuvants Product Portfolio Table 118. Sanofi Recent Development Table 119. Escon Company Information Table 120. Escon Business Overview Table 121. Escon Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 122. Escon Adjuvants Product Portfolio Table 123. Escon Recent Development Table 124. Zhifei Biological Company Information Table 125. Zhifei Biological Business Overview Table 126. Zhifei Biological Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 127. Zhifei Biological Adjuvants Product Portfolio Table 128. Zhifei Biological Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Adjuvants Distributors List Table 132. Adjuvants Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Adjuvants Product Image Figure 2. Global Adjuvants Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Adjuvants Sales Value (2021-2032) & (US$ Million) Figure 4. Global Adjuvants Sales (2021-2032) & (Tons) Figure 5. Global Adjuvants Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Adjuvants Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Emulsion Adjuvants Image Figure 10. Mineral Adjuvants Image Figure 11. Others Image Figure 12. Global Adjuvants Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Adjuvants Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Adjuvants Sales Volume Share by Type (2021-2032) Figure 15. Global Adjuvants Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Adjuvants Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Adjuvants Sales Value Share by Type (2021-2032) Figure 18. Human Vaccine Image Figure 19. Veterinary Vaccine Image Figure 20. Global Adjuvants Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 21. Global Adjuvants Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Adjuvants Sales Volume Share by Application (2021-2032) Figure 23. Global Adjuvants Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Adjuvants Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Adjuvants Sales Value Share by Application (2021-2032) Figure 26. Global Adjuvants Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 27. Global Adjuvants Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Adjuvants Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Adjuvants Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Adjuvants Sales Value (2021-2032) & (US$ Million) Figure 31. North America Adjuvants Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Adjuvants Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Adjuvants Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Adjuvants Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Adjuvants Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Adjuvants Sales Value (2021-2032) & (US$ Million) Figure 37. South America Adjuvants Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Adjuvants Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Adjuvants Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Adjuvants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Adjuvants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Adjuvants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Adjuvants Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Adjuvants Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Emulsion Adjuvants
  • Mineral Adjuvants
  • Others
Applications
  • Human Vaccine
  • Veterinary Vaccine
Companies covered
  • GSK
  • Croda
  • CSL Limited
  • Phibro Animal Health
  • SDA BIO
  • SEPPIC
  • SPI Pharma
  • Vertellus
  • Huanuotai Biological
  • Rico Bio
  • Sanofi
  • Escon
  • Zhifei Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Adjuvants Sales Value (2021-2032)
  4. 1.2.2 Global Adjuvants Sales Volume (2021-2032)
  5. 1.2.3 Global Adjuvants Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Adjuvants Market Dynamics
  1. 2.1 Adjuvants Industry Trends
  2. 2.2 Adjuvants Industry Drivers
  3. 2.3 Adjuvants Industry Opportunities and Challenges
  4. 2.4 Adjuvants Industry Restraints
3 Adjuvants Market by Company
  1. 3.1 Global Adjuvants Company Revenue Ranking in 2025
  2. 3.2 Global Adjuvants Revenue by Company (2021-2026)
  3. 3.3 Global Adjuvants Sales Volume by Company (2021-2026)
  4. 3.4 Global Adjuvants Average Price by Company (2021-2026)
  5. 3.5 Global Adjuvants Company Ranking (2024-2026)
  6. 3.6 Global Adjuvants Company Manufacturing Base and Headquarters
  7. 3.7 Global Adjuvants Company Product Type and Application
  8. 3.8 Global Adjuvants Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Adjuvants Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Adjuvants Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Adjuvants Market by Type
  1. 4.1 Adjuvants Type Introduction
  2. 4.1.1 Emulsion Adjuvants
  3. 4.1.2 Mineral Adjuvants
  4. 4.1.3 Others
  5. 4.2 Global Adjuvants Sales Volume by Type
  6. 4.2.1 Global Adjuvants Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Adjuvants Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Adjuvants Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Adjuvants Sales Value by Type
  10. 4.3.1 Global Adjuvants Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Adjuvants Sales Value by Type (2021-2032)
  12. 4.3.3 Global Adjuvants Sales Value Share by Type (2021-2032)
5 Adjuvants Market by Application
  1. 5.1 Adjuvants Application Introduction
  2. 5.1.1 Human Vaccine
  3. 5.1.2 Veterinary Vaccine
  4. 5.2 Global Adjuvants Sales Volume by Application
  5. 5.2.1 Global Adjuvants Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Adjuvants Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Adjuvants Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Adjuvants Sales Value by Application
  9. 5.3.1 Global Adjuvants Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Adjuvants Sales Value by Application (2021-2032)
  11. 5.3.3 Global Adjuvants Sales Value Share by Application (2021-2032)
6 Adjuvants Regional Sales and Value Analysis
  1. 6.1 Global Adjuvants Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Adjuvants Sales by Region (2021-2032)
  3. 6.2.1 Global Adjuvants Sales by Region: 2021-2026
  4. 6.2.2 Global Adjuvants Sales by Region (2027-2032)
  5. 6.3 Global Adjuvants Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Adjuvants Sales Value by Region (2021-2032)
  7. 6.4.1 Global Adjuvants Sales Value by Region: 2021-2026
  8. 6.4.2 Global Adjuvants Sales Value by Region (2027-2032)
  9. 6.5 Global Adjuvants Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Adjuvants Sales Value (2021-2032)
  12. 6.6.2 North America Adjuvants Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Adjuvants Sales Value (2021-2032)
  15. 6.7.2 Europe Adjuvants Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Adjuvants Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Adjuvants Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Adjuvants Sales Value (2021-2032)
  21. 6.9.2 South America Adjuvants Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Adjuvants Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Adjuvants Sales Value Share by Country, 2025 VS 2032
7 Adjuvants Country-level Sales and Value Analysis
  1. 7.1 Global Adjuvants Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Adjuvants Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Adjuvants Sales by Country (2021-2032)
  4. 7.3.1 Global Adjuvants Sales by Country (2021-2026)
  5. 7.3.2 Global Adjuvants Sales by Country (2027-2032)
  6. 7.4 Global Adjuvants Sales Value by Country (2021-2032)
  7. 7.4.1 Global Adjuvants Sales Value by Country (2021-2026)
  8. 7.4.2 Global Adjuvants Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Adjuvants Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Adjuvants Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Adjuvants Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Adjuvants Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Adjuvants Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Adjuvants Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Adjuvants Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Adjuvants Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Adjuvants Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Adjuvants Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Adjuvants Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Adjuvants Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Adjuvants Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Adjuvants Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Adjuvants Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Adjuvants Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Adjuvants Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Adjuvants Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Adjuvants Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Adjuvants Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Adjuvants Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Adjuvants Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Adjuvants Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Adjuvants Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Adjuvants Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Adjuvants Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Adjuvants Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Adjuvants Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Adjuvants Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Adjuvants Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Adjuvants Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Adjuvants Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Adjuvants Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Adjuvants Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Adjuvants Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Adjuvants Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Adjuvants Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Adjuvants Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Adjuvants Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Adjuvants Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Adjuvants Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Adjuvants Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Adjuvants Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Adjuvants Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Adjuvants Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Adjuvants Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Adjuvants Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Adjuvants Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Adjuvants Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Adjuvants Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Adjuvants Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Adjuvants Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Adjuvants Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Adjuvants Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Adjuvants Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Adjuvants Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Adjuvants Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Adjuvants Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Adjuvants Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Adjuvants Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Adjuvants Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Adjuvants Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Adjuvants Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Adjuvants Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Adjuvants Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Adjuvants Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Adjuvants Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Adjuvants Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Adjuvants Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Adjuvants Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Adjuvants Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Adjuvants Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Adjuvants Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Adjuvants Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Adjuvants Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Adjuvants Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Adjuvants Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Adjuvants Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Adjuvants Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Adjuvants Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Adjuvants Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Adjuvants Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Adjuvants Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Adjuvants Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Adjuvants Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Adjuvants Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Croda
  8. 8.2.1 Croda Company Information
  9. 8.2.2 Croda Business Overview
  10. 8.2.3 Croda Adjuvants Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Croda Adjuvants Product Portfolio
  12. 8.2.5 Croda Recent Developments
  13. 8.3 CSL Limited
  14. 8.3.1 CSL Limited Company Information
  15. 8.3.2 CSL Limited Business Overview
  16. 8.3.3 CSL Limited Adjuvants Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CSL Limited Adjuvants Product Portfolio
  18. 8.3.5 CSL Limited Recent Developments
  19. 8.4 Phibro Animal Health
  20. 8.4.1 Phibro Animal Health Company Information
  21. 8.4.2 Phibro Animal Health Business Overview
  22. 8.4.3 Phibro Animal Health Adjuvants Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Phibro Animal Health Adjuvants Product Portfolio
  24. 8.4.5 Phibro Animal Health Recent Developments
  25. 8.5 SDA BIO
  26. 8.5.1 SDA BIO Company Information
  27. 8.5.2 SDA BIO Business Overview
  28. 8.5.3 SDA BIO Adjuvants Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 SDA BIO Adjuvants Product Portfolio
  30. 8.5.5 SDA BIO Recent Developments
  31. 8.6 SEPPIC
  32. 8.6.1 SEPPIC Company Information
  33. 8.6.2 SEPPIC Business Overview
  34. 8.6.3 SEPPIC Adjuvants Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 SEPPIC Adjuvants Product Portfolio
  36. 8.6.5 SEPPIC Recent Developments
  37. 8.7 SPI Pharma
  38. 8.7.1 SPI Pharma Company Information
  39. 8.7.2 SPI Pharma Business Overview
  40. 8.7.3 SPI Pharma Adjuvants Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 SPI Pharma Adjuvants Product Portfolio
  42. 8.7.5 SPI Pharma Recent Developments
  43. 8.8 Vertellus
  44. 8.8.1 Vertellus Company Information
  45. 8.8.2 Vertellus Business Overview
  46. 8.8.3 Vertellus Adjuvants Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Vertellus Adjuvants Product Portfolio
  48. 8.8.5 Vertellus Recent Developments
  49. 8.9 Huanuotai Biological
  50. 8.9.1 Huanuotai Biological Company Information
  51. 8.9.2 Huanuotai Biological Business Overview
  52. 8.9.3 Huanuotai Biological Adjuvants Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Huanuotai Biological Adjuvants Product Portfolio
  54. 8.9.5 Huanuotai Biological Recent Developments
  55. 8.10 Rico Bio
  56. 8.10.1 Rico Bio Company Information
  57. 8.10.2 Rico Bio Business Overview
  58. 8.10.3 Rico Bio Adjuvants Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Rico Bio Adjuvants Product Portfolio
  60. 8.10.5 Rico Bio Recent Developments
  61. 8.11 Sanofi
  62. 8.11.1 Sanofi Company Information
  63. 8.11.2 Sanofi Business Overview
  64. 8.11.3 Sanofi Adjuvants Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sanofi Adjuvants Product Portfolio
  66. 8.11.5 Sanofi Recent Developments
  67. 8.12 Escon
  68. 8.12.1 Escon Company Information
  69. 8.12.2 Escon Business Overview
  70. 8.12.3 Escon Adjuvants Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Escon Adjuvants Product Portfolio
  72. 8.12.5 Escon Recent Developments
  73. 8.13 Zhifei Biological
  74. 8.13.1 Zhifei Biological Company Information
  75. 8.13.2 Zhifei Biological Business Overview
  76. 8.13.3 Zhifei Biological Adjuvants Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Zhifei Biological Adjuvants Product Portfolio
  78. 8.13.5 Zhifei Biological Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Adjuvants Value Chain Analysis
  2. 9.1.1 Adjuvants Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Adjuvants Sales Mode & Process
  6. 9.2 Adjuvants Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Adjuvants Distributors
  9. 9.2.3 Adjuvants Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst